RaDaR
@renalradar.bsky.social
The largest rare kidney disease registry in the world. A powerful source of real-world data that can help improve understanding of rare kidney conditions.🧬
🧬 Rare kidney disease causes almost all childhood kidney failure, yet many children face delays accessing new therapies.
RaDaR will soon launch a CKD of unknown aetiology Rare Disease Group to help more children join future clinical trials.
Watch this space!
#RareKidneyDisease #CKD #KidneyDisease
RaDaR will soon launch a CKD of unknown aetiology Rare Disease Group to help more children join future clinical trials.
Watch this space!
#RareKidneyDisease #CKD #KidneyDisease
February 5, 2026 at 11:54 AM
🧬 Rare kidney disease causes almost all childhood kidney failure, yet many children face delays accessing new therapies.
RaDaR will soon launch a CKD of unknown aetiology Rare Disease Group to help more children join future clinical trials.
Watch this space!
#RareKidneyDisease #CKD #KidneyDisease
RaDaR will soon launch a CKD of unknown aetiology Rare Disease Group to help more children join future clinical trials.
Watch this space!
#RareKidneyDisease #CKD #KidneyDisease
Throwback Thursday to when the RaDaR team presented #AlportSyndrome data at the FDA in Washington DC.
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj
February 5, 2026 at 11:45 AM
Throwback Thursday to when the RaDaR team presented #AlportSyndrome data at the FDA in Washington DC.
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj